These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27304709)

  • 1. Integrin-Targeting Knottin Peptide-Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation.
    Cox N; Kintzing JR; Smith M; Grant GA; Cochran JR
    Angew Chem Int Ed Engl; 2016 Aug; 55(34):9894-7. PubMed ID: 27304709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A chemically cross-linked knottin dimer binds integrins with picomolar affinity and inhibits tumor cell migration and proliferation.
    Kim JW; Cochran FV; Cochran JR
    J Am Chem Soc; 2015 Jan; 137(1):6-9. PubMed ID: 25486381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted Drug Delivery with an Integrin-Binding Knottin-Fc-MMAF Conjugate Produced by Cell-Free Protein Synthesis.
    Currier NV; Ackerman SE; Kintzing JR; Chen R; Filsinger Interrante M; Steiner A; Sato AK; Cochran JR
    Mol Cancer Ther; 2016 Jun; 15(6):1291-300. PubMed ID: 27197305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gemcitabine anti-proliferative activity significantly enhanced upon conjugation with cell-penetrating peptides.
    Vale N; Ferreira A; Fernandes I; Alves C; Araújo MJ; Mateus N; Gomes P
    Bioorg Med Chem Lett; 2017 Jul; 27(13):2898-2901. PubMed ID: 28495087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enzyme-responsive peptide dendrimer-gemcitabine conjugate as a controlled-release drug delivery vehicle with enhanced antitumor efficacy.
    Zhang C; Pan D; Li J; Hu J; Bains A; Guys N; Zhu H; Li X; Luo K; Gong Q; Gu Z
    Acta Biomater; 2017 Jun; 55():153-162. PubMed ID: 28259838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiophene-expanded guanosine analogues of Gemcitabine.
    Chen Z; Ku TC; Seley-Radtke KL
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4274-6. PubMed ID: 26316465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary evaluation of (177)Lu-labeled knottin peptides for integrin receptor-targeted radionuclide therapy.
    Jiang L; Miao Z; Kimura RH; Liu H; Cochran JR; Culter CS; Bao A; Li P; Cheng Z
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):613-22. PubMed ID: 21153409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, characterization, and in vitro antiproliferative efficacy of gemcitabine conjugates based on carboxymethyl glucan.
    Ma L; Chen Y; Wang X; Xiong M; Sun Y; Zhang X; Zhao Y
    Bioorg Med Chem Lett; 2018 Sep; 28(17):2920-2924. PubMed ID: 30017318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Integrated Drug Screening/Kinome Analysis to Identify Inhibitors of Gemcitabine-Resistant Pancreatic Cancer Cell Growth.
    Krulikas LJ; McDonald IM; Lee B; Okumu DO; East MP; Gilbert TSK; Herring LE; Golitz BT; Wells CI; Axtman AD; Zuercher WJ; Willson TM; Kireev D; Yeh JJ; Johnson GL; Baines AT; Graves LM
    SLAS Discov; 2018 Sep; 23(8):850-861. PubMed ID: 29742358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-Affinity RGD-Knottin Peptide as a New Tool for Rapid Evaluation of the Binding Strength of Unlabeled RGD-Peptides to α
    Bernhagen D; De Laporte L; Timmerman P
    Anal Chem; 2017 Jun; 89(11):5991-5997. PubMed ID: 28492301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of a peptide-paclitaxel conjugate which targets the integrin αvβ₆.
    Li S; Gray BP; McGuire MJ; Brown KC
    Bioorg Med Chem; 2011 Sep; 19(18):5480-9. PubMed ID: 21868241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib.
    Yin N; Yu H; Zhang X; Lv X
    Drug Des Devel Ther; 2020; 14():4465-4475. PubMed ID: 33122890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and evaluation of liver-specific gemcitabine prodrugs for potential treatment of hepatitis C virus infection and hepatocellular carcinoma.
    Stephenson AA; Cao S; Taggart DJ; Vyavahare VP; Suo Z
    Eur J Med Chem; 2021 Mar; 213():113135. PubMed ID: 33454548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineered knottin peptide enables noninvasive optical imaging of intracranial medulloblastoma.
    Moore SJ; Hayden Gephart MG; Bergen JM; Su YS; Rayburn H; Scott MP; Cochran JR
    Proc Natl Acad Sci U S A; 2013 Sep; 110(36):14598-603. PubMed ID: 23950221
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine.
    Tsume Y; Drelich AJ; Smith DE; Amidon GL
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28796151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-assembling, amphiphilic polymer-gemcitabine conjugate shows enhanced antitumor efficacy against human pancreatic adenocarcinoma.
    Chitkara D; Mittal A; Behrman SW; Kumar N; Mahato RI
    Bioconjug Chem; 2013 Jul; 24(7):1161-73. PubMed ID: 23758084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent Immortalized Human Adipose Derived Stromal Cells (hASCs-TS/GFP+) for Studying Cell Drug Delivery Mediated by Microvesicles.
    Cocce V; Balducci L; Falchetti ML; Pascucci L; Ciusani E; Brini AT; Sisto F; Piovani G; Alessandri G; Parati E; Cabeza L; Pessina A
    Anticancer Agents Med Chem; 2017 Nov; 17(11):1578-1585. PubMed ID: 28356007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a C3'-nitrile nucleoside analogue inhibitor of pancreatic cancer cell line growth.
    Labbé MO; Collins L; Lefebvre CA; Maharsy W; Beauregard J; Dostie S; Prévost M; Nemer M; Guindon Y
    Bioorg Med Chem Lett; 2020 Mar; 30(6):126983. PubMed ID: 32019711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regioselective chemical and rapid enzymatic synthesis of a novel redox – Antiproliferative molecular hybrid.
    Geromichalou E; Sayyad N; Kyriakou E; Chatzikonstantinou AV; Giannopoulou E; Vrbjar N; Kalofonos HP; Stamatis H; Tzakos AG
    Eur J Med Chem; 2015; 96():47-57. PubMed ID: 25874330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrin-Mediated Targeted Cancer Therapy Using c(RGDyK)-Based Conjugates of Gemcitabine.
    Chatzisideri T; Leonidis G; Karampelas T; Skavatsou E; Velentza-Almpani A; Bianchini F; Tamvakopoulos C; Sarli V
    J Med Chem; 2022 Jan; 65(1):271-284. PubMed ID: 34967607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.